DEA fee waiver
This article was originally published in The Tan Sheet
Executive Summary
Denying a registration waiver to distributors who handle controlled substances as well as List I chemicals would disproportionately raise fees by requiring them to file separate registrations, four trade organizations state in Jan. 17 comments to the Drug Enforcement Administration. The Consumer Healthcare Products Association, the Food Marketing Institute, the Healthcare Distribution Management Association and the National Association of Chain Drug Stores submitted joint comments addressing the possible removal of the List I registration waiver. "A single controlled substances distributor that is also a List I chemical handler would see a fee increase from $813 to $2,386 - nearly a three-fold increase - under this redundant fee scenario," they state. Maintaining two DEA registration numbers would also create "significant paperwork and operational burdens" for the agency and the industry. The DEA should retain the waiver for List I and controlled substances distributors, and provide information on the anticipated results of such fees, the organizations state...